Identification of Diagnostic and Prognostic MicroRNAs for Recurrent Vitreous Hemorrhage in Patients with Proliferative Diabetic Retinopathy

Overview

Journal J Clin Med

Specialty General Medicine

Date 2019 Dec 19

PMID 31847440

Citations 15

Authors

Parviz Mammadzada

Juliette Bayle

Johann Gudmundsson

Anders Kvanta

Helder Andre

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) can provide insight into the pathophysiological states of ocular tissues such as proliferative diabetic retinopathy (PDR). In this study, differences in miRNA expression in vitreous from PDR patients with and without incidence of recurrent vitreous hemorrhage (RVH) after the initial pars-plana vitrectomy (PPV) were analyzed, with the aim of identifying biomarkers for RVH. Fifty-four consented vitreous samples were analyzed from patients undergoing PPV for PDR, of which eighteen samples underwent a second surgery due to RVH. Ten of the sixty-six expressed miRNAs (miRNAs-19a, -20a, -22, -27a, -29a, -93, -126, -128, -130a, and -150) displayed divergences between the PDR vitreous groups and to the control. A significant increase in the miRNA-19a and -27a expression was determined in PDR patients undergoing PPV as compared to the controls. miRNA-20a and -93 were significantly upregulated in primary PPV vitreous samples of patients afflicted with RVH. Moreover, this observed upregulation was not significant between the non-RVH and control group, thus emphasizing the association with RVH incidence. miRNA-19a and -27a were detected as putative vitreous biomarkers for PDR, and elevated levels of miRNA-20a and -93 in vitreous with RVH suggest their biomarker potential for major PDR complications such as recurrent hemorrhage incidence.

Citing Articles

Detection of microRNAs expression signatures in vitreous humor of intraocular tuberculosis.

Chadalawada S, Rathinam S, Lalitha P, Kannan N, Devarajan B Mol Biol Rep. 2023; 50(12):10061-10072.

PMID: 37906423 DOI: 10.1007/s11033-023-08819-1.

Circulating hsa-miR-221 as a possible diagnostic and prognostic biomarker of diabetic nephropathy.

Abdel-Tawab M, Mohamed M, Doudar N, Rateb E, Reyad H, Elazeem N Mol Biol Rep. 2023; 50(12):9793-9803.

PMID: 37831346 PMC: 10676308. DOI: 10.1007/s11033-023-08846-y.

Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy.

Ding Y, Su N, Luan J, Ni Y, Sun Z J Pers Med. 2023; 13(4).

PMID: 37108958 PMC: 10143612. DOI: 10.3390/jpm13040572.

Systemic inflammatory regulators and proliferative diabetic retinopathy: A bidirectional Mendelian randomization study.

Shi Q, Wang Q, Wang Z, Lu J, Wang R Front Immunol. 2023; 14:1088778.

PMID: 36845092 PMC: 9950638. DOI: 10.3389/fimmu.2023.1088778.

Exosomal miRNA Profiling in Vitreous Humor in Proliferative Diabetic Retinopathy.

Kot A, Kaczmarek R Cells. 2023; 12(1).

PMID: 36611916 PMC: 9818905. DOI: 10.3390/cells12010123.

References

Carthew R, Sontheimer E . Origins and Mechanisms of miRNAs and siRNAs. Cell. 2009; 136(4):642-55. PMC: 2675692. DOI: 10.1016/j.cell.2009.01.035. View

Liang Z, Gao K, Wang Y, Liu Z, Tian L, Yang X . RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy. Am J Physiol Endocrinol Metab. 2018; 315(3):E374-E385. DOI: 10.1152/ajpendo.00021.2018. View

Urbich C, Kuehbacher A, Dimmeler S . Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res. 2008; 79(4):581-8. DOI: 10.1093/cvr/cvn156. View

Yan Z, Zhao J, Gan L, Zhang Y, Guo R, Cao X . CTRP3 is a novel biomarker for diabetic retinopathy and inhibits HGHL-induced VCAM-1 expression in an AMPK-dependent manner. PLoS One. 2017; 12(6):e0178253. PMC: 5478095. DOI: 10.1371/journal.pone.0178253. View

Shi L, Huang Y . Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy. J Res Med Sci. 2013; 17(9):865-71. PMC: 3697213. View

Kim V . MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005; 6(5):376-85. DOI: 10.1038/nrm1644. View

Beck Jr L, DAmore P . Vascular development: cellular and molecular regulation. FASEB J. 1997; 11(5):365-73. View

Yang W, Yang J, Xue L, Xiao L, Li Y . MiR-126 overexpression inhibits high glucose-induced migration and tube formation of rhesus macaque choroid-retinal endothelial cells by obstructing VEGFA and PIK3R2. J Diabetes Complications. 2017; 31(4):653-663. DOI: 10.1016/j.jdiacomp.2016.12.004. View

Zou H, Wang Y, Gang Q, Zhang Y, Sun Y . Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2017; 255(6):1159-1166. DOI: 10.1007/s00417-017-3638-5. View

10.

Tang X, Dai Y, Wang X, Zeng J, Li G . MicroRNA-27a protects retinal pigment epithelial cells under high glucose conditions by targeting TLR4. Exp Ther Med. 2018; 16(1):452-458. PMC: 5995053. DOI: 10.3892/etm.2018.6150. View

11.

Soifer H, Rossi J, Saetrom P . MicroRNAs in disease and potential therapeutic applications. Mol Ther. 2007; 15(12):2070-9. DOI: 10.1038/sj.mt.6300311. View

12.

Menard C, Rezende F, Miloudi K, Wilson A, Tetreault N, Hardy P . MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD. Oncotarget. 2016; 7(15):19171-84. PMC: 4991373. DOI: 10.18632/oncotarget.8280. View

13.

Meng S, Cao J, Zhang X, Fan Y, Fang L, Wang C . Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS One. 2013; 8(7):e68611. PMC: 3709913. DOI: 10.1371/journal.pone.0068611. View

14.

Wakabayashi Y, Usui Y, Okunuki Y, Ueda S, Kimura K, Muramatsu D . Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012; 53(10):6403-10. DOI: 10.1167/iovs.12-10367. View

15.

Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A . Pathophysiology of Diabetic Retinopathy: The Old and the New. Diabetes Metab J. 2018; 42(5):364-376. PMC: 6202564. DOI: 10.4093/dmj.2018.0182. View

16.

Szemraj M, Bielecka-Kowalska A, Oszajca K, Krajewska M, Gos R, Jurowski P . Serum MicroRNAs as Potential Biomarkers of AMD. Med Sci Monit. 2015; 21:2734-42. PMC: 4576928. DOI: 10.12659/MSM.893697. View

17.

Shi L, Kim A, Cheng-An Chang R, Chang J, Ying W, Ko M . Deletion of miR-150 Exacerbates Retinal Vascular Overgrowth in High-Fat-Diet Induced Diabetic Mice. PLoS One. 2016; 11(6):e0157543. PMC: 4909316. DOI: 10.1371/journal.pone.0157543. View

18.

Isner J, Asahara T . Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest. 1999; 103(9):1231-6. PMC: 408362. DOI: 10.1172/JCI6889. View

19.

Saxena K, Rutar M, Provis J, Natoli R . Identification of miRNAs in a Model of Retinal Degenerations. Invest Ophthalmol Vis Sci. 2015; 56(3):1820-9. DOI: 10.1167/iovs.14-15449. View

20.

Bai Y, Bai X, Wang Z, Zhang X, Ruan C, Miao J . MicroRNA-126 inhibits ischemia-induced retinal neovascularization via regulating angiogenic growth factors. Exp Mol Pathol. 2011; 91(1):471-7. DOI: 10.1016/j.yexmp.2011.04.016. View